Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 14 Jul 2023
Although birth control pills have been used by women since the 1960s, researchers are still learning a lot about the body's intricate response to the tiny,.
Read Full NewsAripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.
Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.
In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.
1.
Reducing social media to an hour a day boosts young people's self-image.
2.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
3.
The pandemic had little impact on mental health symptoms.
4.
FDA Approves New Bladder Cancer First-Line Standard of Care.
5.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
1.
Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion
2.
Ferroptosis-Modulating Nanocarriers for Solid Tumor Therapy
3.
Long-Term Wellness After Childhood Cancer Therapy
4.
Innate Lymphoid Cells in Tumor Biology
5.
Understanding Villous Adenoma: Causes, Symptoms, and Treatments
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
5.
A New Era in Managing Cancer-Associated Thrombosis
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge